JAK2 has directly been implicated in the development of Ph‐like B‐ALL by activating mutations, which are predominantly located in its autoinhibitory pseudokinase domain (JH2) (Chen et al, 2012). The gene discussed is JAK2; the disease is acute lymphoblastic leukemia.